Vern Davenport “recently announced his departure” after just over a year on the job as chief executive officer, Medfusion disclosed in an announcement Friday. The news came in an announcement of the Cary company’s promoting a vice president to the CEO role.
Kimberly Labow takes over as CEO after serving as vice president of product management and vice president of marketing.
Steve Malik, the company’s founder and chairman, brought in Davenport, a life science industry veteran, as CEO after he reacquired Medfusion from Intuit. Malik had sold the firm to Intuit for $91 million in 2011 and bought it back in 2013.
Davenport, a former CEO of Raleigh-based MISYS, was recruited to become president of Medfusion in December of 2013. Davenport also became an investor in Medfusion.
His LinkedIn profile still lists him as Medfusion’s CEO.
WRAL TechWire has reached out to Medfusion for comment and will update this story as needed.
Last September, Medfusion, which providers a variety of patient payment and other services, raised $3 million in new capital, and one of the investors – Bull City Ventures – said a reason for the backing was the company’s “perfect combination” in its leadership.
Malink later gave up the CEO post to Davenport but remains executive chairman.
Labow was recruited to Medfusion’s management team last year. She had worked with the firm as vice president of marketing, product management and inside sales. She later worked for NaviNet and ZirMed.
“We were thrilled to have Kim rejoin the Medfusion team last year, and I am even more delighted to now welcome her into the role of CEO where she will have the opportunity to help build the future of the company,” Malik said in the statement. “We are at a pivotal moment in our history as we enhance our focus on further defining and delivering on our vision for comprehensive patient experience management solutions that make healthcare work better for doctors and patients by giving patients consumer-friendly control of their health and care.”
Labow said she was “extremely excited” about her new role.
“Returning to Medfusion has been a real homecoming for me, and my familiarity with the company, its culture, solutions and clients – combined with my experiences in the larger health IT environment – gives me a unique perspective on the needs of the market and how to best serve them,” she said.
In January, Medfusion reached a settlement with healthcare services firm Allscripts in a lawsuit over payments Medfusion said it was due. terms of the settlement were not disclosed.